Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0000899140-25-001145·EUPRAXIA PHARMACEUTICALS INC.
Schedule 13D ownership disclosure
EUPRAXIA PHARMACEUTICALS INC
Common Shares · CUSIP: 29842P105
Event date: 2025-09-24
- Filing-level shares
- 5,533,215
- Percent of class
- 10.2%
- Joseph S. FreedmanReported CIK 0002043590
Shares: 5,533,215 · Class: 10.2%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000899140-25-001145
- Form type
- SCHEDULE 13D/A
- Filer
- EUPRAXIA PHARMACEUTICALS INC.
- CIK
- CIK 1581178
- Filed
- Sep 26, 2025
- Reporting period
- Sep 24, 2025
- Description
- Schedule 13D beneficial ownership